<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20210909</date><key>pmc.key</key><document><id>5990125</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.12688/f1000research.13114.2</infon><infon key="article-id_pmc">5990125</infon><infon key="article-id_pmid">29904574</infon><infon key="elocation-id">2172</infon><infon key="fn">[version 2; referees: 1 approved</infon><infon key="kwd">Multiple sclerosis Machine learning Random Forest collective intelligence Hybrid predictions Crowdsourcing</infon><infon key="license">This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon><infon key="name_0">surname:Tacchella;given-names:Andrea</infon><infon key="name_1">surname:Romano;given-names:Silvia</infon><infon key="name_2">surname:Ferraldeschi;given-names:Michela</infon><infon key="name_3">surname:Salvetti;given-names:Marco</infon><infon key="name_4">surname:Zaccaria;given-names:Andrea</infon><infon key="name_5">surname:Crisanti;given-names:Andrea</infon><infon key="name_6">surname:Grassi;given-names:Francesca</infon><infon key="sec">This version addresses most of the points raised by the Reviewers, to whom we are grateful for useful criticisms. We included several references and statements to justify why we only considered clinical data, not MRI and to document the use of crowdsourcing initiatives in the diagnostic realm. We give more details on how we built the database and on the procedure used to obtain hybrid forecasts, which represent the core of the paper. Finally, we repeatedly state that this work represents a proof of concept of the value of hybrid forecasts, a preliminary step towards deeper studies.</infon><infon key="section_type">TITLE</infon><infon key="title">Amendments from Version 1</infon><infon key="type">front</infon><infon key="volume">6</infon><infon key="year">2017</infon><offset>0</offset><text>Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle study</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>144</offset><text> Background: Multiple sclerosis has an extremely variable natural course. In most patients, disease starts with a relapsing-remitting (RR) phase, which proceeds to a secondary progressive (SP) form. The duration of the RR phase is hard to predict, and to date predictions on the rate of disease progression remain suboptimal. This limits the opportunity to tailor therapy on an individual patient's prognosis, in spite of the choice of several therapeutic options.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>609</offset><text> Approaches to improve clinical decisions, such as collective intelligence of human groups and machine learning algorithms are widely investigated.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>757</offset><text> Methods: Medical students and a machine learning algorithm predicted the course of disease on the basis of randomly chosen clinical records of patients that attended at the Multiple Sclerosis service of Sant'Andrea hospital in Rome.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>991</offset><text> Results: A significant improvement of predictive ability was obtained when predictions were combined with a weight that depends on the consistence of human (or algorithm) forecasts on a given clinical record.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1201</offset><text> Conclusions: In this work we present proof-of-principle that human-machine hybrid predictions yield better prognoses than machine learning algorithms or groups of humans alone. To strengthen and generalize this preliminary result, we propose a crowdsourcing initiative to collect prognoses by physicians on an expanded set of patients.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1538</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1551</offset><text>The natural course of multiple sclerosis (MS) is extremely variable, ranging from extremely mild to very aggressive forms. Most patients experience an initial relapsing-remitting (RR) phase, in which symptoms appear and fade. Eventually, remissions fail and the disease proceeds to a secondary progressive (SP) form, leading to incremental disability. The palette of disease-modifying treatments is becoming relatively large, in principle opening the possibility to tailor the therapy to meet the specific needs of each patient. Unfortunately, the accuracy of parameters to predict the rate of disease progression remains suboptimal.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2185</offset><text>Being all the above therapies preventive, in the absence of exact prognostic indicators we have to accept that a proportion of patients is either under- or over-treated. This is a serious concern as the disease can be severely disabling, and some of the available therapies can lead to adverse events that can be worse than the disease itself. Thus, the possibility to formulate a prognosis as exact as possible is becoming increasingly appealing.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2633</offset><text>In the clinics, as in any other fields of human knowledge, innovative approaches based on machine learning and collective reasoning methods are used in an attempt to succeed where traditional methods of forecasting failed. Machine learning algorithms catch complex relations among existing data to an extent beyond standard regression models. Good performances have been obtained for the diagnosis of Parkinson's disease and the prognosis of disease progression in amyotrophic lateral sclerosis ( ; ). For MS, machine learning algorithms can correctly classify disease course in about 70% of cases of both clinically definite MS and of clinically isolated syndrome ( ; ; ), a good result that still requires improvement to become of clinical value.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3382</offset><text>Through collective reasoning, or collective intelligence, groups of lay people may perform as well as experts. In principle, the larger the group, the higher the prediction accuracy (see for review ), which led to the development of several crowdsourcing initiatives. Possibly, the forerunner was FOLDIT study on protein folding ( ), but crowdsourcing has been exploited also for diagnostic purposes in pathologies, such as breast cancer ( ), skin cancer ( ) or ophtalmology ( ). However, when expert people are involved, even small groups can outperform the best among them, at least when a yes/no answer to well-defined diagnostic questions is requested based on radiographic/histological images, ( ; ; ). Studies with medical students show that working in pairs, either interacting while responding ( ) or aggregating responses ex post ( ), ameliorates diagnostic ability, with further improvements when group size increases ( ; ), in line with the core idea of Collective intelligence. Similar results have been obtained also for prognoses on critically ill patients ( )</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4457</offset><text>Combination of human and machine predictions into hybrid forecasts exploits human intuitive reasoning and computer classification capabilities, potentially boosting both. Indeed, at least in the case of predicting the course of actions in American football games within the frame of prediction markets, hybrid groups performed better than either humans or computers. ( ). In this paper, we report the promising results of a preliminary study on the combination of predictions made by humans with those of a machine learning algorithm on the progression of multiple sclerosis in a set of patients. Both agents (humans and computers) considered clinical data typically available to neurologists during routine visits. Magnetic Resonance Imaging (MRI) data were not included as more clinical than radiological exams are routinely performed (on average 3 visits per year vs. 1 MRI). Moreover, images, acquired and analysed at specialized centres can improve the algorithm performance ( ), but in real world imaging data usually lack the standardization required for analysis, for instance in term of head position reproducibility ( ), and research-grade image analysis is not routinely performed. Conversely, clinical data have recently been shown to have good predictive value ( ). Machine learning and collective intelligence performed almost equally well, but their combination yielded a small, yet statistically significant, improvement in the reliability of the forecasts on disease evolution over different time periods.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5980</offset><text>These results indicate that it is worth deepening the study of human and machine clinical predictions, as well as the potentiality of hybrid predictions, for which we propose a crowdsourcing approach on a platform specifically designed for this analysis ( DiagnoShare).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>6250</offset><text>Methods and results</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6270</offset><text>Dataset structure</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6288</offset><text>Our dataset is composed by clinical records gathered during 527 visits of 84 outpatients followed at the Multiple Sclerosis service of Sant’Andrea hospital in Rome. All patients had clinically definite MS in the RR stage at the time of the visit(s) included in the database and transitioned to the SP phase at some time point. Parameters evaluated during each neurological visit are listed in Supplementary Table 1. Numerical values were provided for each parameter, referring to age, time to complete a task, clinical score or presence/absence of each symptom. For each visit, we noted if the patient was in RR or SP stage after 180, 360 and 720 days, so that predictions could be compared with the true progression of disease in each patient, reported in Supplementary File: TrueOutcomes.xlsx, where 0 means &quot;still in RR phase&quot;, 1 indicates &quot;transitioned to SP phase&quot;. Notice that several patients reached the SP MS stage after the last visit included in the database, so that the number (percentage of entries) of &quot;1&quot; records is 65 (12.3%), 125 (23.7%), and 211 (40.0%) at 180, 360, and 720 days, respectively. Data potentially revealing the identity of the patients was removed from the shared database.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7498</offset><text>Ethics</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7505</offset><text>Use of database for research purposes was authorized by the Ethical committee of Sapienza University (Authorization n. 4254_2016, dated November 2, 2016).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7660</offset><text>Classification with machine learning</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7697</offset><text>Having a correctly labelled dataset ( Supplementary Table 1), in which each entry is associated to the outcome, we used the Random forest supervised approach to classification ( ; ), using the Scikit-learn toolbox version 0.16.1.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7927</offset><text>To benchmark the performance of the trained models, we used a modified leave-one-out approach. Since data was limited (a set of 527 records), and not independent, as it had been obtained from 84 patients, with a simple random leave-one-out the training set would be composed of many correlated same-patient data. Even worse, some of the data from patients present in the training set would be used to validate the model in the benchmarking stage. As a consequence, the model would overfit the training data, misleadingly showing very good performance. Being presented with many data from the same patient, the model optimizes its ability in recognizing patients themselves, through their highly correlated clinical variables.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8653</offset><text>We excluded all visits from one patient from the dataset</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8710</offset><text>We built 50 training sets, each composed by 83 records, taking care to include only one clinical record (randomly chosen) for every remaining patient</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8860</offset><text>We trained 50 Random Forest models, one for each training set.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8923</offset><text>We computed the probability of the transition from RR to SP by averaging the predictions of the 50 models on all the visits of the excluded patient. Predictions consisted in scores from 0 (Extremely unlikely) to 1 (Highly probable).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9156</offset><text>To avoid these problems, we used a modified leave-one-out approach, training the algorithm with the following rules:  </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9275</offset><text>We repeated the procedure for the 84 patients, obtaining an estimation of the probability of the RR to SP transition for each of the 527 clinical records. Three different prediction delays were considered, namely 180, 360 and 720 days. Results obtained are presented in Supplementary File: RF_Predictions.xlsx. The performance of the model was estimated by the Area Under the &quot; Receiver Operating Characteristic&quot; (ROC) Curve (AUC) computed on all the 527 examples. The AUC values obtained are shown in Table 1.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>9786</offset><text>Predictions on disease course by different agents.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; content-type=&quot;article-table&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Agent&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;180 days&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;360 days&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;720 days&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Random Forest&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.710&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.670&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.679&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;Singles (n=42)&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;0.57 ± 0.15&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;0.57 ± 0.11&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;0.57 ± 0.10&lt;/italic&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;Pairs&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;0.68&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;0.65&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;0.65&lt;/italic&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;Group&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;0.703&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;0.667&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;0.666&lt;/italic&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hybrid predictions&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.725
&lt;xref ref-type=&quot;fn&quot; rid=&quot;TFN1&quot;&gt;*&lt;/xref&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.694
&lt;xref ref-type=&quot;fn&quot; rid=&quot;TFN1&quot;&gt;*&lt;/xref&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;top&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.696
&lt;xref ref-type=&quot;fn&quot; rid=&quot;TFN1&quot;&gt;*&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>9837</offset><text>Agent	180 days	360 days	720 days	 	Random Forest	0.710	0.670	0.679	 	Singles (n=42)	0.57 ± 0.15	0.57 ± 0.11	0.57 ± 0.10	 	Pairs	0.68	0.65	0.65	 	Group	0.703	0.667	0.666	 	Hybrid predictions	0.725	 	*	0.694	 	*	0.696	 	*	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>10063</offset><text>For each clinical record, the indicated agents evaluated the probability that disease evolved from the RR to the SP phase after 180, 360 or 720 days. Data represent the AUC values obtained for each method. *: P&lt;0.001 when compared to
Group or Random Forest values at the same time points.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>10352</offset><text>Human predictions</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10370</offset><text>Forty-two medical students in the final two years of their course (Sapienza University, Rome Italy, based within Sant'Andrea hospital), volunteered to participate in the task. All were familiar with clinical records in general, and were instructed on the meaning of each entry present in the medical records of MS patients. This part of the study was approved by the Ethical Committee of the Department of Physiology and Pharmacology, Sapienza University on July 13, 2017.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10843</offset><text>For adequate comparison with computer predictions, students evaluated 50 medical records, collected in a questionnaire, randomly extracted from the same dataset used for machine learning and estimated the probability that the patient would progress to the SP phase within 180, 360 and 720 days. Scores were from 0 (Extremely unlikely) to 5 (Highly probable). Predictions (see Supplementary file Student_Predictions.xlsx) were analysed, using the AUC.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11294</offset><text>On average, each clinical record was evaluated by 4 of the 42 students.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11366</offset><text>Predictions were less accurate than those proposed by machine learning ( Table 1). Standard deviation was larger for the 180 day time point, indicating that opinions on the long-term evolution of the disease are more widely shared, although they are not more precise. To evaluate the impact of collective intelligence, we measured the performance of Pairs, considering all visits evaluated by at least two individual students, randomly selecting only 2 scores when more were available. The prognoses were averaged before computing the AUC, which showed a marked increase ( Table 1). Aggregation of all singles ( Group) yielded a further small increase in the performance of the forecasting ( Table 1), which almost equalled that of random forest algorithm.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>12123</offset><text>Hybrid predictions</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12142</offset><text>We next integrated human and computer predictions into a hybrid prediction, which combines human clinical reasoning with the classification approach of machine learning algorithms. These different &quot;ways of reasoning&quot; possibly lead to quite divergent predictions on individual cases, a complementarity that should be exploited taking the difference into account when creating hybrid predictions.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12537</offset><text>The simplest approach to aggregate forecast is performing a linear or weighted average of the predictions released by humans or computer. For each clinical record at a given time point (180, 360 and 720 days), the final forecast by either agent is the average of “unitary predictions” given by several individuals or decision trees. If “unitary predictions” of one agent are highly concordant, it means that the prediction is quite obvious for the agent, suggesting that it is probably correct. We therefore ranked forecasts on clinical records in order of concordance of “unitary predictions”, for the two agents separately. Then, a normalized ranking was assigned, ranging from 1 for the most consistent predictions to 0 for the most scattered and ranks were squared to emphasize the contribution of the most consistent agent. The hybrid prediction score for each clinical record was then obtained by summing the two squared ranks.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13483</offset><text>Note that a linear combination of rankings resulted in a worse performance of hybrid predictions, as the information about the most consistent prediction between the two agents was be lost. A similarly degraded performance was observed when predictions were not ranked.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13753</offset><text>Since our dataset is relatively small, as is the number of students that evaluated the clinical records, we used a bootstrap procedure to evaluate the statistical significance of the improvement. The bootstrap ( ; ) consists in random sampling of the dataset that allows the estimation of confidence intervals.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14064</offset><text>As shown in Table 1 and Figure 1, hybrid predictions yielded a small but statistically significant (P&lt;0.001) improvement in the prediction of disease course in time. Significance was evaluated from confidence limits using standard methods ( ).</text></passage><passage><infon key="file">f1000research-6-17227-g0000.jpg</infon><infon key="id">f1</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>14308</offset><text>Hybrid Students – Machine Learning predictions outperform both human group and computer alone.</text></passage><passage><infon key="file">f1000research-6-17227-g0000.jpg</infon><infon key="id">f1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>14405</offset><text>The box plot shows the distribution of the AUC obtained from the bootstrap. In particular, the colored boxes correspond to quartiles, while the lines show the full range of the generated AUCs.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>14598</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14609</offset><text>A number of studies have investigated the possibility to increase the appropriateness of clinical decisions through collective intelligence of human groups (for instance, ; ; ) or machine learning algorithms. The latter approach has been used in a great variety of tasks, and its value in the medical realm is possibly overstated ( ). However, machine learning methods performed well for prognostic predictions ( ; ). In particular, the Random forest approach provided good predictions on ALS course ( ).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15114</offset><text>In this work we present proof-of-principle that human-machine hybrid predictions attain prognostic ability above that of machine learning algorithms and groups of humans alone.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15291</offset><text>The duration of the RR phase before its shift into progression has always been difficult to predict, and possibly the random occurrence of relapses ( ) contributes to the lack of univocal indicators. No approach, no matter how good, can yield certainty when cause-effect relations are unknown. Thus, our aim has been to obtain predictions on the probability that MS patients in the RR phase will convert to a SP form within a certain time frame. Predictions on the course of real patients were provided by medical students and a random forest algorithm. A significant improvement of predictive ability was obtained when predictions were combined in a non-linear manner, with a weight that depends on the consistence of human (or algorithm) forecasts on a given clinical record.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16069</offset><text>This result can be considered in agreement with several studies on different medical issues showing that predictor's confidence correlates very well with the correctness of the prediction ( ; ; ; ). Indeed, the concordance of different members of a given group (students or runs of the random forest model) can be taken as indicating that the agent is &quot;sure&quot; of the forecast. Further work investigating the best ways to combine predictions of different agents is ongoing.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16541</offset><text>In spite of the relatively basic machine learning technique used, the small number of students involved and their limited clinical knowledge, this work suggests that hybrid predictions can be useful to improve the prognosis of MS course. A deeper study is therefore of interest, to evaluate how general this conclusion is. To recruit more and more skilled humans, we propose a crowdsourcing initiative called DiagnoShare that is being advertised among physicians.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17005</offset><text>A reliable tool to predict MS progression can be of aid to clinicians to tailor therapy to each patient, but also in clinical trials, to evaluate whether drugs modify the estimated outcome of each enrolled patient, as proposed for ALS ( ).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17245</offset><text>In the long run, it is possible that further developments in our ability to combine collective reasoning and machine predictions will have a profound impact also on the organization and management of medical care, particularly in hospital settings.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>17494</offset><text>Data availability</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>17512</offset><text>The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2018 Tacchella A et al.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>17646</offset><text>Data associated with the article are available under the terms of the Creative Commons Zero &quot;No rights reserved&quot; data waiver (CC0 1.0 Public domain dedication).  </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>17809</offset><text>Dataset 1: True outcome of patients, indexed as clinical records. More than one clinical record is pertinent to each patient. T_180, T_360, T_720: clinical conditions of the patient 180, 360 and 720 days after the visit in which clinical record was obtained. 0: still in RR phase; 1: transitioned to SP phase. DOI: 10.5256/f1000research.13114.d188355 ( )</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>18164</offset><text>Dataset 2: Predictions on individual clinical records made by medical students. Each student worked on a questionnaire (lines labelled &quot;questionnaire&quot;, column B.) listing 50 clinical reports (lines labelled &quot;Clinical report N&quot;, columns B to AY) and made a prediction on the probability of RR –to–SP transition within 180, 360 and 720 days (lines labelled Prediction @ 180, 360, 720, columns B to AY)</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>18568</offset><text>The numbering of Clinical reports is the same used in Dataset 1. DOI: 10.5256/f1000research.13114.d188356 ( )</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>18678</offset><text>Dataset 3: Predictions on individual clinical records made by a Random Forest algorithm. Score_180, Score_360, Score_720: Probability that the patient will transition to SP phase within 180, 360 and 720 days after the visit in which clinical record was obtained. The numbering of Clinical reports is the same used in Dataset 1. DOI: 10.5256/f1000research.13114.d188357 ( )</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>19051</offset><text>Supplementary material</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>19074</offset><text>Supplementary Table 1: Parameters evaluated for each patient and included in clinical records.</text></passage><passage><infon key="fpage">d2304</infon><infon key="name_0">surname:Altman;given-names:DG</infon><infon key="name_1">surname:Bland;given-names:JM</infon><infon key="pub-id_doi">10.1136/bmj.d2304</infon><infon key="pub-id_pmid">22803193</infon><infon key="section_type">REF</infon><infon key="source">BMJ.</infon><infon key="type">ref</infon><infon key="volume">343</infon><infon key="year">2011</infon><offset>19169</offset><text>How to obtain the P value from a confidence interval.</text></passage><passage><infon key="fpage">910321</infon><infon key="name_0">surname:Bordi;given-names:I</infon><infon key="name_1">surname:Umeton;given-names:R</infon><infon key="name_2">surname:Ricigliano;given-names:VA</infon><infon key="pub-id_doi">10.1155/2013/910321</infon><infon key="pub-id_pmid">23671846</infon><infon key="section_type">REF</infon><infon key="source">Int J Genomics.</infon><infon key="type">ref</infon><infon key="volume">2013</infon><infon key="year">2013</infon><offset>19223</offset><text>A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.</text></passage><passage><infon key="fpage">5</infon><infon key="issue">1</infon><infon key="lpage">32</infon><infon key="name_0">surname:Breiman;given-names:L</infon><infon key="pub-id_doi">10.1023/A:1010933404324</infon><infon key="section_type">REF</infon><infon key="source">Mach Learn.</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2001</infon><offset>19316</offset><text>Random Forests.</text></passage><passage><infon key="fpage">681</infon><infon key="issue">7</infon><infon key="lpage">689</infon><infon key="name_0">surname:Candido Dos Reis;given-names:FJ</infon><infon key="name_1">surname:Lynn;given-names:S</infon><infon key="name_2">surname:Ali;given-names:HR</infon><infon key="pub-id_doi">10.1016/j.ebiom.2015.05.009</infon><infon key="pub-id_pmid">26288840</infon><infon key="section_type">REF</infon><infon key="source">EBioMedicine.</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">2015</infon><offset>19332</offset><text>Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer.</text></passage><passage><infon key="fpage">2507</infon><infon key="issue">26</infon><infon key="lpage">2509</infon><infon key="name_0">surname:Chen;given-names:JH</infon><infon key="name_1">surname:Asch;given-names:SM</infon><infon key="pub-id_doi">10.1056/NEJMp1702071</infon><infon key="pub-id_pmid">28657867</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med.</infon><infon key="type">ref</infon><infon key="volume">376</infon><infon key="year">2017</infon><offset>19420</offset><text>Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations.</text></passage><passage><infon key="fpage">756</infon><infon key="issue">7307</infon><infon key="lpage">60</infon><infon key="name_0">surname:Cooper;given-names:S</infon><infon key="name_1">surname:Khatib;given-names:F</infon><infon key="name_2">surname:Treuille;given-names:A</infon><infon key="pub-id_doi">10.1038/nature09304</infon><infon key="pub-id_pmid">20686574</infon><infon key="section_type">REF</infon><infon key="source">Nature.</infon><infon key="type">ref</infon><infon key="volume">466</infon><infon key="year">2010</infon><offset>19508</offset><text>Predicting protein structures with a multiplayer online game.</text></passage><passage><infon key="fpage">2187</infon><infon key="issue">21</infon><infon key="lpage">2195</infon><infon key="name_0">surname:Detsky;given-names:ME</infon><infon key="name_1">surname:Harhay;given-names:MO</infon><infon key="name_2">surname:Bayard;given-names:DF</infon><infon key="pub-id_doi">10.1001/jama.2017.4078</infon><infon key="pub-id_pmid">28528347</infon><infon key="section_type">REF</infon><infon key="source">JAMA.</infon><infon key="type">ref</infon><infon key="volume">317</infon><infon key="year">2017</infon><offset>19570</offset><text>Discriminative Accuracy of Physician and Nurse Predictions for Survival and Functional Outcomes 6 Months After an ICU Admission.</text></passage><passage><infon key="fpage">e0157077</infon><infon key="issue">8</infon><infon key="name_0">surname:Dinov;given-names:ID</infon><infon key="name_1">surname:Heavner;given-names:B</infon><infon key="name_2">surname:Tang;given-names:M</infon><infon key="pub-id_doi">10.1371/journal.pone.0157077</infon><infon key="pub-id_pmid">27494614</infon><infon key="section_type">REF</infon><infon key="source">PLoS One.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2016</infon><offset>19699</offset><text> Predictive Big Data Analytics: A Study of Parkinson’s Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.</text></passage><passage><infon key="name_0">surname:Efron;given-names:B</infon><infon key="name_1">surname:Tibshirani;given-names:RJ</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">1994</infon><offset>19856</offset><text>An introduction to the bootstrap.</text></passage><passage><infon key="fpage">783</infon><infon key="issue">4</infon><infon key="lpage">791</infon><infon key="name_0">surname:Felsenstein;given-names:J</infon><infon key="pub-id_doi">10.1111/j.1558-5646.1985.tb00420.x</infon><infon key="pub-id_pmid">28561359</infon><infon key="section_type">REF</infon><infon key="source">Evolution.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">1985</infon><offset>19890</offset><text>CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP.</text></passage><passage><infon key="fpage">4443</infon><infon key="lpage">6</infon><infon key="name_0">surname:Fiorini;given-names:S</infon><infon key="name_1">surname:Verri;given-names:A</infon><infon key="name_2">surname:Tacchino;given-names:A</infon><infon key="pub-id_doi">10.1109/EMBC.2015.7319381</infon><infon key="pub-id_pmid">26737281</infon><infon key="section_type">REF</infon><infon key="source">Conf Proc IEEE Eng Med Biol Soc.</infon><infon key="type">ref</infon><infon key="volume">2015</infon><infon key="year">2015</infon><offset>19957</offset><text> A machine learning pipeline for multiple sclerosis course detection from clinical scales and patient reported outcomes.</text></passage><passage><infon key="fpage">1352458518773511</infon><infon key="name_0">surname:Goodin;given-names:DS</infon><infon key="name_1">surname:Reder;given-names:AT</infon><infon key="name_2">surname:Traboulsee;given-names:AL</infon><infon key="pub-id_doi">10.1177/1352458518773511</infon><infon key="pub-id_pmid">29761737</infon><infon key="section_type">REF</infon><infon key="source">Mult Scler.</infon><infon key="type">ref</infon><infon key="year">2018</infon><offset>20078</offset><text>Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.</text></passage><passage><infon key="fpage">303</infon><infon key="issue">3</infon><infon key="lpage">304</infon><infon key="name_0">surname:Hautz;given-names:WE</infon><infon key="name_1">surname:Kämmer;given-names:JE</infon><infon key="name_2">surname:Schauber;given-names:SK</infon><infon key="pub-id_doi">10.1001/jama.2014.15770</infon><infon key="pub-id_pmid">25603003</infon><infon key="section_type">REF</infon><infon key="source">JAMA.</infon><infon key="type">ref</infon><infon key="volume">313</infon><infon key="year">2015</infon><offset>20185</offset><text>Diagnostic performance by medical students working individually or in teams.</text></passage><passage><infon key="fpage">715</infon><infon key="issue">6</infon><infon key="lpage">724</infon><infon key="name_0">surname:Kämmer;given-names:JE</infon><infon key="name_1">surname:Hautz;given-names:WE</infon><infon key="name_2">surname:Herzog;given-names:SM</infon><infon key="pub-id_doi">10.1177/0272989X17696998</infon><infon key="pub-id_pmid">28355975</infon><infon key="section_type">REF</infon><infon key="source">Med Decis Making.</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2017</infon><offset>20262</offset><text>The Potential of Collective Intelligence in Emergency Medicine: Pooling Medical Students' Independent Decisions Improves Diagnostic Performance.</text></passage><passage><infon key="fpage">979</infon><infon key="issue">6</infon><infon key="lpage">84</infon><infon key="name_0">surname:King;given-names:AJ</infon><infon key="name_1">surname:Gehl;given-names:RW</infon><infon key="name_2">surname:Grossman;given-names:D</infon><infon key="pub-id_doi">10.1016/j.canep.2013.09.004</infon><infon key="pub-id_pmid">24075797</infon><infon key="section_type">REF</infon><infon key="source">Cancer Epidemiol.</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2013</infon><offset>20407</offset><text>Skin self-examinations and visual identification of atypical nevi: comparing individual and crowdsourcing approaches.</text></passage><passage><infon key="fpage">8777</infon><infon key="issue">31</infon><infon key="lpage">8782</infon><infon key="name_0">surname:Kurvers;given-names:RH</infon><infon key="name_1">surname:Herzog;given-names:SM</infon><infon key="name_2">surname:Hertwig;given-names:R</infon><infon key="pub-id_doi">10.1073/pnas.1601827113</infon><infon key="pub-id_pmid">27432950</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci U S A.</infon><infon key="type">ref</infon><infon key="volume">113</infon><infon key="year">2016</infon><offset>20525</offset><text>Boosting medical diagnostics by pooling independent judgments.</text></passage><passage><infon key="fpage">51</infon><infon key="issue">1</infon><infon key="lpage">57</infon><infon key="name_0">surname:Küffner;given-names:R</infon><infon key="name_1">surname:Zach;given-names:N</infon><infon key="name_2">surname:Norel;given-names:R</infon><infon key="pub-id_doi">10.1038/nbt.3051</infon><infon key="pub-id_pmid">25362243</infon><infon key="section_type">REF</infon><infon key="source">Nat Biotechnol.</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2015</infon><offset>20588</offset><text>Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.</text></passage><passage><infon key="fpage">18</infon><infon key="lpage">22</infon><infon key="name_0">surname:Liaw;given-names:A</infon><infon key="name_1">surname:Wiener;given-names:M</infon><infon key="section_type">REF</infon><infon key="source">R News.</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">2002</infon><offset>20687</offset><text>Classification and regression by random Forest.</text></passage><passage><infon key="name_0">surname:Nagar;given-names:Y</infon><infon key="name_1">surname:Malone;given-names:TW</infon><infon key="section_type">REF</infon><infon key="source">Proceedings of the International Conference on Information Systems ICIS 2011.
</infon><infon key="type">ref</infon><infon key="year">2011</infon><offset>20735</offset><text>Making Business Predictions by Combining Human and Machine Intelligence in Prediction Markets.</text></passage><passage><infon key="fpage">627</infon><infon key="issue">7</infon><infon key="lpage">8</infon><infon key="name_0">surname:Ponsonby;given-names:AL</infon><infon key="name_1">surname:Mattingly;given-names:K</infon><infon key="pub-id_doi">10.1016/j.ebiom.2015.06.005</infon><infon key="pub-id_pmid">26288829</infon><infon key="section_type">REF</infon><infon key="source">EBioMedicine.</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">2015</infon><offset>20830</offset><text>Evaluating New Ways of Working Collectively in Science with a Focus on Crowdsourcing.</text></passage><passage><infon key="fpage">1874</infon><infon key="issue">9</infon><infon key="lpage">8</infon><infon key="name_0">surname:Poses;given-names:RM</infon><infon key="name_1">surname:Bekes;given-names:C</infon><infon key="name_2">surname:Winkler;given-names:RL</infon><infon key="pub-id_doi">10.1001/archinte.1990.00390200068013</infon><infon key="pub-id_pmid">2393319</infon><infon key="section_type">REF</infon><infon key="source">Arch Intern Med.</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">1990</infon><offset>20916</offset><text>Are two (inexperienced) heads better than one (experienced) head? Averaging house officers' prognostic judgments for critically ill patients.</text></passage><passage><infon key="fpage">590</infon><infon key="issue">4</infon><infon key="lpage">601</infon><infon key="name_0">surname:Sonabend;given-names:AM</infon><infon key="name_1">surname:Zacharia;given-names:BE</infon><infon key="name_2">surname:Cloney;given-names:MB</infon><infon key="pub-id_doi">10.1227/NEU.0000000000001374</infon><infon key="pub-id_pmid">27509070</infon><infon key="section_type">REF</infon><infon key="source">Neurosurgery.</infon><infon key="type">ref</infon><infon key="volume">80</infon><infon key="year">2017</infon><offset>21058</offset><text>Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.</text></passage><passage><infon key="name_0">surname:Tacchella;given-names:A</infon><infon key="name_1">surname:Romano;given-names:S</infon><infon key="name_2">surname:Ferraldeschi;given-names:M</infon><infon key="pub-id_doi">10.5256/f1000research.13114.d188355</infon><infon key="section_type">REF</infon><infon key="source">F1000Research.</infon><infon key="type">ref</infon><infon key="year">2017a</infon><offset>21155</offset><text>Dataset 1 in: Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle study.</text></passage><passage><infon key="name_0">surname:Tacchella;given-names:A</infon><infon key="name_1">surname:Romano;given-names:S</infon><infon key="name_2">surname:Ferraldeschi;given-names:M</infon><infon key="pub-id_doi">10.5256/f1000research.13114.d188356</infon><infon key="section_type">REF</infon><infon key="source">F1000Research.</infon><infon key="type">ref</infon><infon key="year">2017b</infon><offset>21314</offset><text> Dataset 2 in: Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle study.</text></passage><passage><infon key="name_0">surname:Tacchella;given-names:A</infon><infon key="name_1">surname:Romano;given-names:S</infon><infon key="name_2">surname:Ferraldeschi;given-names:M</infon><infon key="pub-id_doi">10.5256/f1000research.13114.d188357</infon><infon key="section_type">REF</infon><infon key="source">F1000Research.</infon><infon key="type">ref</infon><infon key="year">2017c</infon><offset>21474</offset><text> Dataset 3 in: Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle study.</text></passage><passage><infon key="fpage">256</infon><infon key="issue">3</infon><infon key="lpage">61</infon><infon key="name_0">surname:Wang;given-names:X</infon><infon key="name_1">surname:Mudie;given-names:L</infon><infon key="name_2">surname:Brady;given-names:CJ</infon><infon key="pub-id_doi">10.1097/ICU.000000000000025</infon><infon key="pub-id_pmid">26761188</infon><infon key="section_type">REF</infon><infon key="source">Curr Opin Ophthalmol.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2016</infon><offset>21634</offset><text>Crowdsourcing: an overview and applications to ophthalmology.</text></passage><passage><infon key="fpage">75</infon><infon key="issue">1</infon><infon key="lpage">84</infon><infon key="name_0">surname:Weinstock-Guttman;given-names:B</infon><infon key="name_1">surname:Medin;given-names:J</infon><infon key="name_2">surname:Khan;given-names:N</infon><infon key="pub-id_doi">10.1007/s40263-017-0482-4</infon><infon key="pub-id_pmid">29270772</infon><infon key="section_type">REF</infon><infon key="source">CNS Drugs.</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2018</infon><offset>21696</offset><text>Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study.</text></passage><passage><infon key="fpage">e0134269</infon><infon key="issue">8</infon><infon key="name_0">surname:Wolf;given-names:M</infon><infon key="name_1">surname:Krause;given-names:J</infon><infon key="name_2">surname:Carney;given-names:PA</infon><infon key="pub-id_doi">10.1371/journal.pone.0134269</infon><infon key="pub-id_pmid">26267331</infon><infon key="section_type">REF</infon><infon key="source">PLoS One.</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2015</infon><offset>21983</offset><text>Collective intelligence meets medical decision-making: the collective outperforms the best radiologist.</text></passage><passage><infon key="fpage">281</infon><infon key="lpage">7</infon><infon key="name_0">surname:Wottschel;given-names:V</infon><infon key="name_1">surname:Alexander;given-names:DC</infon><infon key="name_2">surname:Kwok;given-names:PP</infon><infon key="pub-id_doi">10.1016/j.nicl.2014.11.021</infon><infon key="pub-id_pmid">25610791</infon><infon key="section_type">REF</infon><infon key="source">Neuroimage Clin.</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2014</infon><offset>22087</offset><text> Predicting outcome in clinically isolated syndrome using machine learning.</text></passage><passage><infon key="fpage">e0174866</infon><infon key="issue">4</infon><infon key="name_0">surname:Zhao;given-names:Y</infon><infon key="name_1">surname:Healy;given-names:BC</infon><infon key="name_2">surname:Rotstein;given-names:D</infon><infon key="pub-id_doi">10.1371/journal.pone.0174866</infon><infon key="pub-id_pmid">28379999</infon><infon key="section_type">REF</infon><infon key="source">PLoS One.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2017</infon><offset>22163</offset><text> Exploration of machine learning techniques in predicting multiple sclerosis disease course.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>22256</offset><text>10.5256/f1000research.14226.r31371</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>22291</offset><text>Referee response for version 1</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>22322</offset><text>Menze</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>22328</offset><text>Bjoern</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>22335</offset><text>2018</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>22340</offset><text> General: </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>22351</offset><text> I think exploring how to fuse multiple expert opinions is a very interesting line of research in computer aided diagnostics. Here, the authors test how to make use of lay persons, and I would agree that there are many tasks when a (briefly trained) lay person or non-expert can contribute significantly to an analytical task.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>22678</offset><text> In the application here, I would be rather critical about this approach, though. For example, the authors write &quot;through collective reasoning, or collective intelligence, groups of lay people may perform as well as experts.&quot; I would not agree, by any means. How would a lay person without training be able to distinguish, for example, a stroke related white matter hyper-intensity from an MS lesion? Or even a large MR artifact? Averaging will reduce variance in prediction, but the individual prediction itself has to be unbiased. In other words: the layman predictor has to be correct on average. But how would they possibly be in case they have no idea about how to read these data? Moreover, the authors point out that &quot;studies with medical students show that working in pairs ameliorates diagnostic ability&quot;. Is this because of a better discussion of the decision? With two subjects it cannot be the power of large numbers that this study relies on.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>23634</offset><text> Instead of exploring how to fuse layman's decisions, I would recommend the authors to explore how to fuse decisions of different algorithms, or from neurologists of different training/seniority level, or decisions based on different sources.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>23877</offset><text> Technical: </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>23890</offset><text> Experimental setup and evaluation: The authors describe a &quot;leave-one patient-out&quot; cross-validation as an innovation of their study. While this is a good approach, it is not new.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>24069</offset><text> Algorithm and training: There are different classes - what is the distribution of those classes for the 84 patients? What is in the reports? Numbers? Free text? What features are input to the random forest algorithm? How many features at all? How did you train the algorithm (parameters &quot;mtry&quot;, why 50 trees?) Without this information it is difficult to assess whether the performance of your random forest is bad (i.e., close to layman's predictions) because of an suboptimal training procedure, or because this is a hard problem indeed.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>24609</offset><text> Fusion rule: (Described in the section &quot;To compare the two sets... of the most consistent agent.&quot;) I don't understand what you do. How does summing a squared ranking lead to a prediction score? I assume you are using the normalized (and squared) ranking as a sort of weight? Why do you square the rankings? What happens when you use other non-linear transformations? Is there any way you illustrate the distributions so that we can follow your reasoning? How about presenting simple rules like averaging, or majority voting at least as a baseline we can compare against?</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>25181</offset><text>I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>25386</offset><text>Grassi</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>25393</offset><text>Francesca</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>25403</offset><text>2018</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>25408</offset><text>First of all, thank you for taking the time to read our work and to give useful comments. We hope that our responses will clear your doubts. We list below the changes introduced in the new version, prompted by your observations. We hope that you agree with us that it is improved</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>25688</offset><text> In the application here, I would be rather critical about this approach, though. For example, the authors write &quot;through collective reasoning, or collective intelligence, groups of lay people may perform as well as experts.&quot; I would not agree, by any means. How would a lay person without training be able to distinguish, for example, a stroke related white matter hyper-intensity from an MS lesion? Or even a large MR artifact? Averaging will reduce variance in prediction, but the individual prediction itself has to be unbiased. In other words: the layman predictor has to be correct on average. But how would they possibly be in case they have no idea about how to read these data? </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>26376</offset><text> ANSWER</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>26384</offset><text> Although your point of view is quite understandable, there is a large body of literature on the topic of collective intelligence. In the hope to overcome your skepticism on this point, we added some more references to published work on diagnostic crowdsourcing initiatives.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>26659</offset><text> Moreover, the authors point out that &quot;studies with medical students show that working in pairs ameliorates diagnostic ability&quot;. Is this because of a better discussion of the decision? With two subjects it cannot be the power of large numbers that this study relies on. </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>26930</offset><text> ANSWER</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>26938</offset><text> It is now better explained that the two quoted studies use different methods: real pairs in one, aggregated opinions in the other, yet both obtain better performances. Authors do not discuss the underlying processes, so we cannot indicate the real reason of a better performance.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>27219</offset><text> Instead of exploring how to fuse layman's decisions, I would recommend the authors to explore how to fuse decisions of different algorithms, or from neurologists of different training/seniority level, or decisions based on different sources.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>27462</offset><text> ANSWER</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>27470</offset><text> Thank you for your suggestion. Understanding that we have to deepen out study (now repeatedly stated throughout the paper) we have developed DiagnoShare to obtain the predictions of clinicians of different expertise and we are investigating the performance of algorithm combinations.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>27755</offset><text> Experimental setup and evaluation: The authors describe a &quot;leave-one patient-out&quot; cross-validation as an innovation of their study. While this is a good approach, it is not new. </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>27935</offset><text> ANSWER</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>27943</offset><text> Thank you for your observation. Indeed, it is better to define our approach as a modified leave-one-out method. It is modified, because we not only left one patient out, we also included only one record for each of the remaining patients.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>28183</offset><text> Algorithm and training:  There are different classes - what is the distribution of those classes for the 84 patients? What is in the reports? Numbers? Free text? What features are input to the random forest algorithm? How many features at all? How did you train the algorithm (parameters &quot;mtry&quot;, why 50 trees?) Without this information it is difficult to assess whether the performance of your random forest is bad (i.e., close to layman's predictions) because of an suboptimal training procedure, or because this is a hard problem indeed </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>28724</offset><text> ANSWER</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>28732</offset><text> Thank you for pointing out that this part of the paper required clarification. As now better emphasized in the text, in this proof-of-concept work we considered only patients that actually transitioned to the SP phase, so there is a unique class of patients. Features input to the RF algorithm are listed in Supplementary Table 1. We added a statement to declare what types of numerical values we used in the work. The results presented show that the RF algorithm performs better than layman, as its performance is however better than that of individual medical students, that are not quite laymen, although not experts as well. In any case, the focus of the paper is not on the goodness of the algorithm, but on the value of combining different approaches to the prediction problem, which indeed has been resisting solution for many years of medical analysis.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>29594</offset><text> Fusion rule:  (Described in the section &quot;To compare the two sets... of the most consistent agent.&quot;) I don't understand what you do. How does summing a squared ranking lead to a prediction score? I assume you are using the normalized (and squared) ranking as a sort of weight? Why do you square the rankings? What happens when you use other non-linear transformations? Is there any way you illustrate the distributions so that we can follow your reasoning? How about presenting simple rules like averaging, or majority voting at least as a baseline we can compare against? </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>30168</offset><text> ANSWER</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>30176</offset><text> We agree with you that, indeed, this point is complex and we try a different explanation, hoping that it is clearer. First of all, ranking is inherent to building a ROC curve. Since we have only two agents (humans and RF algorithm), we cannot use a majority rule, we can only perform an average (linear or weighted) of the scores. For any clinical record, the final forecast is the average of &quot;unitary predictions&quot; by multiple individuals or decision trees. If &quot;unitary predictions&quot; of one agent are highly concordant, it means that the prediction is quite obvious for the agent, suggesting that is more probably correct than others. We ranked forecasts on clinical records in order of concordance of &quot;unitary predictions&quot; and emphasized the value of agreement by squaring the ranks.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>30961</offset><text> In line with other pieces of research, this weighted average performed better than linear averaging, as stated in the paper</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31086</offset><text>10.5256/f1000research.14226.r31369</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>31121</offset><text>Referee response for version 1</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31152</offset><text>Tam</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31156</offset><text>Roger</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31162</offset><text>2018</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31167</offset><text>This is an interesting and clearly written article on using a machine learning method (random forests) and medical students to form &quot;hybrid&quot; predictions of disease progression in MS, specifically the conversion from RRMS to SPMS. The article claims that the results are a proof-of-principle that combining machine learning and human predictions is better than either approach alone. </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31552</offset><text> The main strengths of the article are its clear writing, the reproducbility of the experiments, the clinical importance of the application, and topical nature of the subject, as machine learning for clinical prediction is such a hot topic that integration with the clinical workflow is a critical area of study.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31865</offset><text> The main limitations of the article are that only clinical parameters were used to perform the predictions, and the longitudinal nature of the data was not used to its full benefit. To realize the potential of machine learning for MS prediction, imaging parameters should be included (there is good literature on MS prediction using imaging), and examining changes over time is important for both machine (eg, using recurrent networks) and human raters (examining clinical changes over multiple time points). The article places some importance on having the computer and humans using the same set of input parameters, but I do not feel that this is warranted; the data should be selected to be most appropriate for each approach.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>32596</offset><text> Given the above limitations, it is difficult to generalize the findings to say that hybrid predictions are better than either machine learning or humans. This could be true, and the article provides some support for that, but more work needs to be done to provide strong evidence.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>32878</offset><text>I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>33083</offset><text>Grassi</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>33090</offset><text>Francesca</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>33100</offset><text>2018</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>33105</offset><text>First of all, thank you for taking the time to read our work and to give useful comments. We hope that our responses will clear your doubts. We list below the changes introduced in the new version, prompted by your observations. We hope that you agree with us that it is improved.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>33386</offset><text> The main limitations of the article are that only clinical parameters were used to perform the predictions, and the longitudinal nature of the data was not used to its full benefit. To realize the potential of machine learning for MS prediction, imaging parameters should be included (there is good literature on MS prediction using imaging), and examining changes over time is important for both machine (eg, using recurrent networks) and human raters (examining clinical changes over multiple time points). The article places some importance on having the computer and humans using the same set of input parameters, but I do not feel that this is warranted; the data should be selected to be most appropriate for each approach. </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>34118</offset><text> ANSWER</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>34126</offset><text> We agree with you that many other approaches could be used. As now stated in the text, we chose to explore predictions done using only clinical data, available to all neurologists, which have recently been independently demonstrated to have good predictive value (Goodin et al., 2018; reference added to the paper). Imaging data performed in real-world clinical settings do not have the standardization required for predictions either by experts or algorithms. However, future studies aimed at confirming this proof-of-principle, initial work will surely consider different options.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>34710</offset><text> Given the above limitations, it is difficult to generalize the findings to say that hybrid predictions are better than either machine learning or humans. This could be true, and the article provides some support for that, but more work needs to be done to provide strong evidence. </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>34993</offset><text> ANSWER</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35001</offset><text> We completely agree with you that this is a preliminary, proof-of-concept work. We state it more clearly in the Discussion</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35125</offset><text>10.5256/f1000research.14226.r30349</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>35160</offset><text>Referee response for version 1</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35191</offset><text>Bonetti</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35199</offset><text>Bruno</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35205</offset><text>2018</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35210</offset><text>The manuscript is interesting and intriguing, since it opens new possibilities in MS prognosis combining human expertise and &quot;artificial intelligence&quot;. I do not understand why medical students have been chosen instead of (young) neurologists who may have additional skills in the specific task. Apart from this aspect, the manuscript is well written and easy to follow. Deserves publication.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35602</offset><text>I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35747</offset><text>Grassi</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35754</offset><text>Francesca</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35764</offset><text>2018</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35769</offset><text>Thank you very much for reviewing our paper.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35814</offset><text>In this proof-of-concept study, we chose to work with medical students instead of neurologists because we wanted to test if even a group of relatively uneducated people can enhance the predictive ability of machine learning algorithms, which is now well established.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>36081</offset><text>We agree with you that the next step is to obtain predictions by neurologists and other medical doctors, and in fact we set up the platform DiagnoShare ( http://www.phys.uniroma1.it/diagnoshare) to extend the study.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>36297</offset><text>Hopefully, we can soon extend this work with a final study</text></passage></document></collection>
